The uk national institute for health and care excellence (nice) issues final draft guidance to provide patients with a natural lens (phakic eye) being treated for chronic diabetic macular edema access to iluvien®

Nice final draft guidance recommends providing national health system (nhs) patients with a phakic lens access to the only sustained-release treatment lasting up to 36 months for chronic diabetic macular edema (dme) nice final draft guidance recommends providing national health system (nhs) patients with a phakic lens access to the only sustained-release treatment lasting up to 36 months for chronic diabetic macular edema (dme)
ALIM Ratings Summary
ALIM Quant Ranking